Tenofovir alafenamide hemifumarate, also known as Tenofovir alafenamide fumarate (2:1), is a nucleotide reverse transcriptase inhibitor (NRTIs) and a novel prodrug of tenofovir. By blocking reverse transcriptase, TAF prevents HIV from multiplying and can reduce the amount of HIV in the body.
Tenofovir Alafenamide Fumarate Market contains market size and forecasts of Tenofovir Alafenamide Fumarate in global, including the following market information:
- Global Tenofovir Alafenamide Fumarate Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Tenofovir Alafenamide Fumarate Market Sales, 2017-2022, 2023-2028, (Tons)
- Global top five Tenofovir Alafenamide Fumarate companies in 2021 (%)
The global Tenofovir Alafenamide Fumarate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
- The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
- Purity 97% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
- The global key manufacturers of Tenofovir Alafenamide Fumarate include AFINE CHEMICALS LIMITED, BOC Sciences, ENBRIDGE PHARMTECH, SimSon Pharma Limited, Valorpharm and Watson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
- We surveyed the Tenofovir Alafenamide Fumarate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tenofovir Alafenamide Fumarate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Tenofovir Alafenamide Fumarate Market Segment Percentages, by Type, 2021 (%)
- Purity 97%
- Purity 98%
- Purity 99%
Global Tenofovir Alafenamide Fumarate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Tenofovir Alafenamide Fumarate Market Segment Percentages, by Application, 2021 (%)
- Medicine
- Chemical Industry
- Other
Global Tenofovir Alafenamide Fumarate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Tenofovir Alafenamide Fumarate Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Tenofovir Alafenamide Fumarate revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Tenofovir Alafenamide Fumarate revenues share in global market, 2021 (%)
- Key companies Tenofovir Alafenamide Fumarate sales in global market, 2017-2022 (Estimated), (Tons)
- Key companies Tenofovir Alafenamide Fumarate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AFINE CHEMICALS LIMITED
- BOC Sciences
- ENBRIDGE PHARMTECH
- SimSon Pharma Limited
- Valorpharm
- Watson
Industry Market Size
